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 Summary 
This report shows how asthma and chronic obstructive pulmonary disease (COPD) 
hospitalisations vary across Australia. It also examines the association between these 
hospitalisation rates and socioeconomic status (SES), remoteness and the proportion of 
Indigenous Australians in different locations across Australia. 
Maps presented in this report show higher hospitalisation rates for both asthma and COPD 
in inland Australia and rural areas. Asthma hospitalisation rates are also higher in certain 
coastal areas in Queensland, in south-east South Australia and in south Western Australia. In 
comparison, COPD hospitalisation rates are higher in much of the Northern Territory and 
north-west Western Australia. 
Further investigation found that SES, remoteness and the proportion of the population that 
identifies as Indigenous all had a significant association with the hospitalisation rates for 
asthma and COPD by area. 
There may be further reasons for the variation in hospitalisation rates for asthma and COPD, 
such as: 
• location specific factors, such as air pollution and allergic triggers 
• access to hospital and primary care services 
• variation in smoking rates. 
These issues could be explored in further studies. 
 
vi   
 1 Introduction 
This report investigates the geographic distribution of hospitalisation for asthma and chronic 
obstructive pulmonary disease (COPD) in Australia. 
Asthma is a chronic inflammatory condition of the airways associated with episodes of 
wheezing, breathlessness and chest tightness. The symptoms of asthma are usually 
reversible, either spontaneously or with treatment.  
There is evidence that environmental and lifestyle factors, as well as genetic factors (such as 
an allergic tendency) increase the risk of developing asthma (GINA 2011).  
Among those with asthma, symptoms can be triggered by exposure to allergens such as 
house dust mites, pollens and mould spores. Symptoms can also be triggered by viral 
infections, exercise, air pollutants, tobacco smoke and occupational allergens or irritants.  
COPD is a serious long-term lung disease that mainly affects middle-aged to older adults. 
The term COPD encompasses bronchitis and emphysema. It is characterised by airflow 
limitation that is not fully reversible with treatment. People with the disease may experience 
shortness of breath as well as cough, phlegm and wheeze.  
Tobacco smoking is the predominant cause of COPD (Forey et al. 2011). However, there is 
evidence that genetic and/or other environmental factors are involved. Exposure to outdoor 
air pollution, occupational fumes and dusts, as well as a history of pulmonary tuberculosis, 
childhood respiratory infections, or chronic asthma are all associated with an increased risk 
of COPD (Salvi & Barnes 2009).  
Among those with COPD, exacerbations can be triggered by viral or bacterial infections as 
well as exposure to environmental pollutants (Celli & Barnes 2007). 
It is estimated that nearly 10% of the Australian population have asthma. Prevalence data for 
COPD is less clear, however, it is believed that among those aged 55 and over, at least 5% 
have COPD (AIHW: ACAM 2011).  
1.1  What do we already know about the distribution 
of asthma and COPD? 
Many studies have suggested that asthma and COPD have a greater impact on particular 
population groups (AIHW: ACAM 2011). 
The prevalence of asthma (estimated from self-reported data from the 2007–08 National 
Health Survey, or NHS) tends to be significantly higher in people living in areas with lower 
socioeconomic status (SES) than in people living in areas with higher SES. The prevalence of 
asthma is also significantly higher in people living in Inner regional areas than in those living 
in Major cities (AIHW: ACAM 2011). 
Similar disparities have been noted in relation to hospitalisations for asthma, which are 
higher for: 
• people living in areas with lower SES compared with those living in areas with higher 
SES 
• adults living in Remote areas compared with adults living in Major cities 
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 • Aboriginal and Torres Strait Islander people compared with Other Australians (for ages 
5 and over) 
• people from an English-speaking background compared with those from a 
non-English-speaking background (AIHW: ACAM 2011).  
The prevalence of COPD (estimated from self-reported data from the 2007–08 NHS) among 
people aged 55 and over does not differ between people living in Major cities, Inner regional 
areas or Other areas (covering Outer regional and Remote categories of remoteness) (AIHW: 
ACAM 2011). 
COPD hospitalisations are higher for: 
• people living in areas with lower SES compared with those living in areas with higher 
SES  
• people living in Remote areas compared with Major cities 
• Indigenous Australians compared with Other Australians 
• people from an English-speaking background compared with those from a 
non-English-speaking background (AIHW: ACAM 2011).  
The variation in the impact of the disease between population groups noted for asthma and 
COPD is similar to that for many health conditions. For example, in 2007–08, overall 
hospitalisation rates were higher for Indigenous Australians than Other Australians. 
Hospitalisation rates were higher in the fifth of the population with the lowest SES compared 
with the fifth of the population with the highest SES, and in more remote areas compared 
with urban areas (AIHW 2009).  
1.2 Purpose of this report 
This report aims to provide information about how asthma and COPD hospitalisations vary 
across Australia. It looks at the role played in this variation by socioeconomic status, 
remoteness and proportion of Indigenous Australians in different locations across Australia.  
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 2 Methods 
2.1  Data 
Regions investigated 
The report investigates regions in Australia called Statistical Sub-divisions (SSDs). There are 
217 SSDs in Australia with population numbers ranging from 280 to 517,000 and with an 
average population of 99,000. In aggregate, SSDs cover the whole of Australia without gaps 
or overlays. The SSD boundaries were calculated by the Australian Bureau of Statistics (ABS) 
(ABS 2006b). Eight SSDs covering offshore and migratory areas were excluded from the 
analysis. 
Hospitalisation data 
Hospital separations for asthma and COPD were extracted from the Australian Institute of 
Health and Welfare (AIHW) National Hospital Morbidity Database (NHMD) for July 2007 to 
June 2010. A hospital separation is defined as an episode of care for an admitted patient, 
which can be a total hospital stay or a portion of a hospital stay beginning or ending in a 
change of type of care (AIHW 2011).  
Hospital separations were extracted from the NHMD when asthma or COPD was the 
principal diagnosis (the diagnosis of the problem that was the main reason for admission). 
Hospital separations were also extracted from the NHMD for all causes combined for 
comparison purposes.  
In the NHMD, the hospital separation records contain information about the Statistical Local 
Area (SLA) of usual residence of the patient (where the patient usually lives, not where they 
were treated). This information can be used to identify the SSD of usual residence of the 
patient, as SLAs are smaller areas that fit within SSDs. 
See Appendix B Section B.1 for the codes used and a further discussion of SLA information. 
Age ranges 
This report focuses on asthma hospitalisations for people aged 5–34 and COPD 
hospitalisations for people aged 55+. The diagnosis of asthma is most certain in the age range 
5–34 and COPD is an uncommon cause of hospitalisation in people aged under 55. 
Time period  
Due to the small numbers involved, 3 years of hospital separation data were combined to 
create larger, more stable numbers and allow analysis for small geographic areas. This report 
combined data from the 2007–08, 2008–09 and 2009–10 financial years.  
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 2.2  Calculating and interpreting hospitalisation 
rates 
Calculation of hospital separation rates  
Hospital separation rates for asthma and COPD were calculated by dividing the average 
yearly number of hospital separations in each SSD by the estimated SSD population within 
the specified age range. The hospital separations were taken from 2007–08 to 2009–10, and 
this number was divided by three to give the average yearly number of hospital separations 
across this 3-year period. The rate for hospital separations is different to a rate for the 
number of people hospitalised, as in some cases one person’s stay in hospital will generate 
multiple separations. Estimated resident populations (ERPs) based on the mid-year 2006 
Census of Population of Housing provided the most recent Census-based estimates of SSD 
population size. All data in this report were based on the 2006 SSD boundaries set by the 
ABS.  
The hospital separation rates by SSD were not age-standardised, however, the rates were 
limited to ages 5–34 for asthma and 55+ for COPD.  
Exclusion of SSDs with unstable rates due to low populations 
SSDs with fewer than 1,000 people in the age range of interest were not presented. The low 
hospital separation numbers in these SSDs gave rise to rates that were unstable and subject 
to higher uncertainty.  
For the asthma analysis, two SSDs had fewer than 1,000 people in the 5–34 age range. For the 
COPD analysis, eight SSDs had fewer than 1,000 people in the 55+ age range. These SSDs are 
listed in Appendix B, Section B.2. 
How can SSDs with high or low rates be interpreted? 
Hospitalisation rates can reflect demand, supply and admission practices. 
A higher rate of hospital separations for a particular condition in a SSD may indicate: 
• a higher prevalence of the more severe cases of the condition that require hospital 
treatment 
• a higher prevalence of comorbidities that increase the likelihood of hospitalisation 
• a higher level of access to hospital (including different thresholds for admission) 
• less or poorer quality care available within the primary health care setting 
• a higher rate of re-admission to hospital due to poorer management of the condition 
across the hospital and non-hospital settings 
• a greater propensity of doctors to use diagnostic terms that are coded as asthma or 
COPD. 
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 2.3  Investigating how the hospitalisation rates vary 
by location 
This report tests the hypothesis that the variation in hospitalisation rates for asthma and 
COPD is significantly affected by location.  
Strictly speaking, any variation between SSDs could be taken as an influence of location. It is 
assumed, however, that some variation will occur between SSDs due to random factors and 
factors unrelated or partially related to location, such as SES and the proportion of the SSD 
population that identifies as Indigenous.  
It is also assumed that the degree of this variation will be influenced by the volume of 
hospitalisations for the condition. That is, if a condition has a high rate of hospitalisation, we 
expect to see more variation in the hospitalisation rates for the condition between SSDs, due 
to a larger scope for random effects. Therefore, because hospitalisations for COPD are far 
more common than for asthma, we assume that the variation in hospitalisation rates for 
COPD will be greater than for asthma.  
This raises a question of how the variation in hospital separation rates by SSD can be tested, 
to ascertain if location is a statistically significant predictor of SSD separation rates. Four 
methods for interpreting this variation were used.  
Mapping the data 
The hospitalisation rates for asthma and COPD by SSD are presented on a map of Australia 
(Chapter 3). The hospitalisation rates by SSD are also shown for the five most highly 
populated cities in Australia, and surrounding regions, as well as the Australian Capital 
Territory and Tasmania (Appendix A). The hospitalisation rates were divided into quartiles 
and each quartile is shown in a different colour. SSDs with fewer than 1,000 people in the age 
range of interest were not used in the analysis, and are shown on the maps in white.  
These maps give an overview of the range of asthma and COPD hospitalisation rates in 
Australia, however, larger SSDs are given more prominence when the data are displayed in 
this form, and smaller SSDs are given less prominence.  
Measuring the variation in the data 
Interdecile range method 
The variation in hospitalisation rates by SSD for asthma or COPD was measured using the 
‘interdecile range’. Deciles divide a data set into 10 parts, each containing an equal number 
of observations. The interdecile range is the difference between the first and the tenth deciles. 
Thus, the interdecile range covers the inner 80% of the spread of a data set. This measure was 
chosen because it takes into account the spread of the majority of the data, but is not 
influenced by outlying values. If the variation in hospitalisation rates by SSD is high, the 
interdecile range will be large.  
Coefficient of variation method 
The coefficient of variation is another measure of the variation present in a data set. It has the 
advantage over the interdecile range that it corrects for the magnitude of the values in the 
data set. This is useful because when a condition is common, it is more likely to have a wide 
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 distribution of hospitalisation rates. Thus, when comparing the variation in hospitalisations 
for conditions that differ in prevalence, it is desirable to correct for this effect. 
The coefficient of variation is calculated by taking a measure of the spread of a data set and 
dividing it by a measure of the magnitude of the values in the data set. Specifically, it is 
calculated by dividing the standard deviation of the data set by the mean of the data set.  
In this report, the coefficient of variation was calculated for the asthma and COPD 
hospitalisations by SSD, and compared with the distribution of hospitalisations for all causes 
by SSD, for the corresponding age ranges. The distribution of all-cause hospitalisations by 
SSD is a useful data set for comparison to assess the relative degree of variability between 
conditions.  
Poisson regression method 
A regression model was used to investigate the extent to which variation in hospitalisation 
rates by SSD could be explained by variation in SES, remoteness and the proportion of 
Indigenous Australians in the SSD. A regression model was fitted to the hospitalisation data 
for asthma, and a separate regression model was fitted to the hospitalisation data for COPD. 
A Poisson model was chosen for the analysis because this model gave a better fit to the data 
than a multiple linear model.  
The generalised coefficient of determination, also called the generalised R2, is the proportion 
of variability in a data set that is accounted for by the statistical model. Once the Poisson 
regression model has been fitted, this measure indicates how much of the variation in 
hospitalisations by SSD can be accounted for by variation in SES, remoteness and the 
proportion of Indigenous Australians. This measure is expressed as a percentage. A result of 
0% means that none of the variation can be explained by the chosen variables, and a result of 
100% means that all of the variation can be explained by the chosen variables. The method 
used to calculate the generalised R2 in this report is in Appendix C, Section C.1.  
The SES and remoteness of the SSD, as well as the proportion of Indigenous Australians in 
the SSD, were considered as explanatory variables in the regression models. There is good 
reason to expect that these variables are correlated (an issue called ‘collinearity’), so the 
model with the greatest R2 may not include all three variables. For information about these 
three measures, see Appendix B, Section B.3. 
The three explanatory variables were run in separate Poisson models. A final model was 
chosen by testing all possible models using the three explanatory variables and choosing the 
combination of variables that gave the highest explanatory power (R2), where each included 
variable was required to make a statistically significant contribution to the model.  
The statistical significance of the Poisson model was tested using a goodness-of-fit chi-
squared test (UCLA 2012b). If this test returns a P value that is greater than 0.05, it can be 
concluded that the regression model fits the data well. 
Appendix C contains a discussion of three technical issues related to the regression: 
overdispersion, collinearity and spatial autocorrelation. 
Investigation of the top 10 SSDs 
The 10 SSDs with the highest hospitalisation rates for asthma or COPD are presented. The 
median SES, median remoteness and average proportion of Indigenous Australians for the 
10 SSDs were compared with the corresponding values for the full set of SSDs under study 
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 (the set of SSDs under study excludes SSDs with fewer than 1000 population in the age 
range). It was necessary to use the median rather than the average for SES and remoteness, 
as the intervals between the values of these variables are not evenly spaced.  
2.4 Data quality statements 
A data quality statement for the National Hospital Morbidity Database can be found at the 
following location: 
<http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421911>. 
A data quality statement for the 2006 ABS Census of Population and Housing can be found 
at the following location: 
<http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Census+Data+Quality#Relevan
ce>. 
2.5  Computer packages  
The results for this report were extracted and analysed using SAS Enterprise Guide Version 
4.3, Microsoft Excel 2010 and MapInfo Professional Version 11.0. 
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 3 Results 
3.1  Hospitalisation rates 
Asthma hospitalisations 
A map of the asthma hospitalisation rates by SSD for Australia is shown in Figure 3.1.  
Portions of this map have been enlarged in Appendix A, which includes images of the five 
most populous Australian cities, as well as the Australian Capital Territory and Tasmania.  
The map of asthma hospitalisation rates by SSD in Australia shows clusters of SSDs with 
high hospitalisation rates in inland Australia. The map also shows high hospitalisation rates 
in certain coastal areas of Queensland, as well as in the south-east corner of South Australia, 
and the southern part of Western Australia. The additional maps in Appendix A show 
clusters of SSDs with lower asthma hospitalisation rates in urban areas. 
There are a range of reasons why a particular SSD may have a higher rate of hospitalisations. 
See Section 2.2 for an overview of these issues.  
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 Notes  
1. This analysis is limited to ages 5–34.  
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ procurement have 
been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure 3.1: Asthma hospitalisation rates by SSD, 2007–08 to 2009–10 
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 COPD hospitalisations 
A map of the COPD hospitalisation rates by SSD for Australia is shown in Figure 3.2.  
Portions of this map have been enlarged in Appendix A, which includes images of the five 
most populous Australian cities, as well as the Australian Capital Territory and Tasmania.  
The map of COPD hospitalisation rates by SSD in Australia shows a band of SSDs with high 
hospitalisation rates in inland areas, much of the Northern Territory and the north-west 
corner of Western Australia. The additional maps in Appendix A show a pattern of lower 
COPD hospitalisation rates in urban areas compared with rural areas. 
An overview of the reasons why a particular SSD may have a higher rate of hospitalisations 
is in Section 2.2.  
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 Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ procurement have 
been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure 3.2: COPD hospitalisation rates by SSD, 2007–08 to 2009–10 
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 3.2  Variation in the hospitalisation rates 
Asthma hospitalisations 
The range of hospitalisation rates for asthma across the different SSDs in Australia is 
presented in Figure 3.3. Eighty per cent of the SSDs had between 86 and 248 hospitalisations 
per 100,000 population per year. The interdecile range in this case was 162 hospitalisations 
per 100,000 population per year (see Section 2.3).  
The coefficient of variation was 0.40 for the asthma hospitalisations and 0.22 for all-cause 
hospitalisations (see Section 2.3). This result shows that once the magnitude of the 
hospitalisation rates is corrected for, asthma hospitalisations show far greater variation 
(almost double) by SSD than all cause hospitalisations. This suggests that location factors 
play a more important role for asthma hospitalisations than for all-cause hospitalisations. 
 
 
Notes 
1. This analysis is limited to ages 5–34. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure 3.3: Distribution of hospitalisation rates for asthma by SSD, 2007–08 to 2009–10  
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 COPD hospitalisations 
Figure 3.4 shows the range of hospitalisation rates for COPD across the different SSDs in 
Australia. Eighty per cent of the SSDs had between 751 and 1,987 hospitalisations per 100,000 
population per year. Therefore, the interdecile range was 1,236 hospitalisations per 100,000 
population per year (see Section 2.3).  
The coefficient of variation was 0.38 for the COPD hospitalisations and 0.24 for all-cause 
hospitalisations (see Section 2.3). This result shows that once the magnitude of the 
hospitalisation rates is corrected for, COPD hospitalisations show far greater variation by 
SSD than all-cause hospitalisations. This suggests that location factors play a more important 
role for COPD hospitalisations than for all-cause hospitalisations. 
 
Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure 3.4: Distribution of hospitalisation rates for COPD by SSD, 2007–08 to 2009–10 
3.3  Poisson regression models 
Asthma hospitalisations 
A Poisson regression model was fitted to the hospitalisation data for asthma by SSD. Three 
variables were considered—the SES of the SSD, the remoteness of the SSD and the 
proportion of the SSD population who were Indigenous Australians.  
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 To explore the possible contribution of each of the variables to a model, the three variables 
were each used as the only explanatory variable in a Poisson model. The model using the 
SES of the SSD had a generalised R2 value of 45%, and therefore this variable accounted for 
45% of the variation in asthma hospitalisations by SSD. The model using the remoteness of 
the SSD had a generalised R2 value of 10%. The model using the proportion of Indigenous 
Australians in the SSD had a generalised R2 value of 2%.  
The model using the SES of the SSD found that the asthma hospitalisation rate was twice as 
high for SSDs in the lowest SES quintile as SSDs in the highest SES quintile. 
No conclusions could be drawn about the relationship between remoteness and 
hospitalisation rates because, although the model was statistically significant as a whole, the 
comparisons of hospitalisation rates between the five different remoteness areas were not 
significant.  
According to the model using the proportion of Indigenous Australians in the SSD, the 
asthma hospitalisation rate was higher in SSDs with a higher proportion of Indigenous 
Australians. The model predicted an increase in the hospitalisation rate by a factor of 1.01 for 
every percentage increase in the proportion of the SSD population who were Indigenous 
Australians. 
The proportion of Indigenous Australians in each SSD and the remoteness of the SSD were 
not included in the final model for asthma hospitalisations because, likely due to correlations 
with SES of the SSD, neither variable made a statistically significant contribution to the 
model once the SES of the SSD was included. The final model for asthma hospitalisations 
used one explanatory variable—the SES of the SSD. This model accounted for 45% of the 
variation in asthma hospitalisations by SSD. (This value—45%—is the generalised R2.) This 
R2 value indicates that this model accounts for a reasonable proportion of the variation in 
asthma hospitalisations by SSD. However, it also suggests that it is likely that there are 
additional explanatory variables, not investigated in this work, that would explain some of 
the variation in hospitalisations. 
Based on this model, as previously mentioned, the asthma hospitalisation rate was larger by 
a factor of 2 in SSDs in the lowest SES quintile compared with SSDs in the highest SES 
quintile. The model was found to be statistically significant at the 95% confidence level. 
The details of these models are in Appendix D, Section D.1. 
COPD hospitalisations 
A Poisson regression model was fitted to the hospitalisation data for COPD by SSD. Three 
variables were considered—the SES of the SSD, the remoteness of the SSD and the 
proportion of Indigenous Australians in the SSD.  
To explore the possible contribution of each of the variables to a model, the three variables 
were each used as the only explanatory variable in a Poisson model. The model using the 
SES of the SSD had a generalised R2 value of 50%. The model using the remoteness of the 
SSD had a generalised R2 value of 21%, and the model using the proportion of Indigenous 
Australians in the SSD had a generalised R2 value of 18%. 
The model using the SES of the SSD found that the COPD hospitalisation rate was larger by a 
factor of 2 in SSDs in the lowest SES quintile compared with SSDs in the highest SES quintile.  
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 As was the case for asthma, no conclusions could be drawn about the relationship between 
remoteness and hospitalisation rates because, although the model was statistically significant 
as a whole, the comparisons of hospitalisation rates between the five different remoteness 
areas were not significant.  
According to the model using the proportion of Indigenous Australians in the SSD, the 
COPD hospitalisation rate was higher in SSDs with a higher proportion of Indigenous 
Australians. The model predicted an increase in the hospitalisation rate by a factor of 1.03 for 
every percentage increase in the proportion of the SSD population who were Indigenous 
Australians. 
The final model for COPD hospitalisations used two explanatory variables—the SES and the 
proportion of Indigenous Australians in the SSD. The remoteness of the SSD was removed 
from the model because it did not make a statistically significant contribution to the model, 
likely due to a correlation with the other two variables. This model accounted for 55% of the 
variation in COPD hospitalisations by SSD (This value—55%—is the generalised R2). This R2 
value indicates that this model accounts for a reasonable proportion of the variation in 
COPD hospitalisations by SSD, but it is likely that other factors not investigated here also 
play a role. 
The model was found to be statistically significant at the 95% confidence level. 
Based on this model, COPD hospitalisation rates were higher in SSDs with a higher 
proportion of Indigenous Australians by a factor of 1.02 for every percentage increase in the 
proportion of Indigenous Australians. The model also found that COPD hospitalisation rates 
were larger by a factor of 1.8 in SSDs in the lowest SES quintile compared with SSDs in the 
highest SES quintile. These findings differ slightly from the findings for the single variable 
models due to the interaction between the two variables.  
The details of these models are in Appendix D, Section D.2. 
3.4  Characteristics of the top 10 SSDs 
Asthma hospitalisations 
The 10 SSDs with the highest rates of asthma hospitalisation for July 2007 to June 2010 had 
between 282 and 438 asthma hospitalisations per 100,000 population per year. The average 
asthma hospitalisation rate for the full asthma data set of SSDs was 161 per 100,000 
population per year.  
The top 10 SSDs had a lower median SES than the SSDs in the full asthma data set. The top 
10 SSDs had a median SES that fell in the lowest SES group, and the full asthma data set had 
a median SES that fell in the second-lowest SES group.  
The top 10 SSDs had a higher median remoteness than the SSDs in the full asthma data set. 
The top 10 SSDs had a median level of remoteness between Inner regional and Outer Regional, 
compared with the median level of remoteness for the full asthma data set of Inner Regional. 
The remoteness index is based on how distant a place is by road from urban centres of 
varying sizes, and therefore provides a relative indication of how difficult it might be for 
residents to access certain services, such as health care and education.  
The average proportion of Indigenous Australians for the top 10 SSDs was 5.1%, slightly 
lower than the average proportion in the full asthma data set of 6.7%. 
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 COPD hospitalisations 
The 10 SSDs with the highest rates of COPD hospitalisation from July 2007 to June 2010 had 
between 2,949 and 7,384 COPD hospitalisations per 100,000 population per year. The average 
COPD hospitalisation rate for the full COPD data set of SSDs was 1,181 per 100,000 
population per year.  
The top 10 SSDs had a lower median SES and higher median remoteness than the SSDs in the 
full COPD data set. The top 10 SSDs had a median SES that fell in the lowest SES group, and 
the full COPD data set had a median SES that fell in the second-lowest SES group. The top 10 
SSDs had a median level of remoteness of Remote, compared with the median level of 
remoteness for the full COPD data set of Inner Regional.  
Many of the top 10 SSDs had a high proportion of Indigenous Australians. The average 
proportion of Indigenous Australians for these top 10 SSDs was 23.4%. The average 
proportion of Indigenous Australians in the full COPD data set was 5.2%. 
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 4 Discussion 
 
This report presents information about the variation in asthma and COPD hospitalisations 
across Australia. A regression model was used to show that SES, remoteness and the 
proportion of the population that identifies as Indigenous had a statistically significant effect 
on hospitalisation rates for these conditions.  
There are many additional reasons why hospitalisations for asthma or COPD may be higher 
in one SSD compared with another. The hospitalisation rates in an SSD may be affected by 
various factors, including the prevalence of the condition, the management of the condition 
(for example, access to non-hospital health care) as well as the presence of comorbidities that 
increase the likelihood of hospitalisation. Environmental factors such as air pollution or the 
presence of allergic triggers may also play a role.  
In future, other measures of the impact of asthma and COPD at SSD level could be used in 
combination with hospitalisations information. For example, emergency department 
presentations or pharmaceutical use for these conditions could be taken into account. 
Analysis of pharmaceutical use will be more feasible in the future, due to substantial 
improvements from 1 April 2012 in the coverage of national prescription data available as a 
by-product of the Pharmaceutical Benefits Scheme (which will now include information 
about all prescriptions filled regardless of whether they were under or over a copayment 
threshold).  
It would also be useful to identify the proportion of hospital separations due to  
re-admissions. This can be an indicator of poor health system management of a condition. 
This type of analysis is feasible in a technical sense and opportunities for such analysis are 
likely to improve in the future, building on the development of hospital readmission 
indicators for the National Healthcare Agreement and the National Health Reform 
Agreement’s Performance and Accountability Framework. 
It may also be possible to identify other location factors that contributed to the variation in 
asthma or COPD hospitalisation rates. In particular, it would be interesting to investigate the 
impact of environmental factors such as pollens, moulds, outdoor air pollution and seasonal 
weather events. Additionally, social determinants of health could be further investigated. 
Finally, investigation of the association between smoking rates and hospitalisation rates for 
asthma and COPD would be an interesting area for future analysis.  
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 Appendix A Additional maps 
Asthma hospitalisations 
 
Notes 
1. This analysis is limited to ages 5–34.  
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented.  
4. This analysis is based on 2006 SSD boundaries.  
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A1: Asthma hospitalisation rates by SSD, Sydney and surrounds, 2007–08 to 2009–10 
 
  
Sydney 
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Notes 
1. This analysis is limited to ages 5–34. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A2: Asthma hospitalisation rates by SSD, Melbourne and surrounds, 2007–08 to 2009–10 
 
  
Melbourne 
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Notes 
1. This analysis is limited to ages 5–34. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented.  
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure A3: Asthma hospitalisation rates by SSD, Brisbane and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 5–34.  
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A4: Asthma hospitalisation rates by SSD, Perth and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 5–34. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries.  
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A5: Asthma hospitalisation rates by SSD, Adelaide and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 5–34. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries.  
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn - unqualified days only, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure A6: Asthma hospitalisation rates by SSD, Australian Capital Territory, 2007–08 to 
2009–10 
North Canberra 
South 
Canberra 
Weston 
Creek 
Namadgi National Park 
Belconnen 
Woden 
Tuggeranong 
Gungahlin 
Geographic distribution of asthma and COPD hospitalisations 23 
  
Notes 
1. This analysis is limited to ages 5–34.  
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 5–34 were not presented. 
4. This analysis is based on 2006 SSD boundaries.  
5. Data extracted using the principal diagnosis of J45–J46 for asthma. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure A7: Asthma hospitalisation rates by SSD, Tasmania, 2007–08 to 2009–10 
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 COPD hospitalisations 
 
Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented.  
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing.  
Figure A8: COPD hospitalisation rates by SSD, Sydney and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A9: COPD hospitalisation rates by SSD, Melbourne and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented.  
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A10: COPD hospitalisation rates by SSD, Brisbane and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A11: COPD hospitalisation rates by SSD, Perth and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A12: COPD hospitalisation rates by SSD, Adelaide and surrounds, 2007–08 to 2009–10 
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Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A13: COPD hospitalisation rates by SSD, Australian Capital Territory, 2007–08 
to 2009–10 
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Notes 
1. This analysis is limited to ages 55+. 
2. The rates presented here are the average yearly rates for 2007–08 to 2009–10.  
3. SSDs with populations of fewer than 1,000 in the age range 55+ were not presented. 
4. This analysis is based on 2006 SSD boundaries. 
5. Data extracted using the principal diagnosis of J40–J44 for COPD. 
6. Hospital separations for which the care type was reported as Newborn with no qualified days, Hospital boarders or Posthumous organ 
procurement have been excluded. 
Source: AIHW analysis of the AIHW National Hospital Morbidity Database and ABS ERPs from the 2006 Census of Population and Housing. 
Figure A14: COPD hospitalisation rates by SSD, Tasmania, 2007–08 to 2009–10 
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 Appendix B Technical information 
B.1  Coding information for the NHMD 
Asthma was coded as J45–J46 and COPD as J40–J44 using the International Statistical 
Classification of Diseases and Related Health Problems, 10th revision, Australian 
Modification (ICD-10-AM) (NCCH 2006; NCCH 2008). This coding scheme was based on the 
World Health Organization’s version of ICD-10. The fifth edition of the Australian 
Modification was used for 2007–08 and the sixth edition was used for 2008–09 and 2009–10. 
The classification and coding guidelines for asthma and COPD did not change over this 
period. Separations with a care type of Newborn (without qualified days) and records for 
Hospital boarders and Posthumous organ procurement were excluded from the analysis.  
The data quality of the diagnosis information in the NHMD is, generally speaking, very 
good. However, asthma and COPD can be difficult to distinguish. In some cases it is possible 
that a patient was assigned a principal diagnosis of asthma or COPD when the other 
condition may have better described the underlying issue.  
In the NHMD, the hospital separation records contain information about the SLA of usual 
residence of the patient (where the patient usually lives, not where they were treated). This 
information can be used to identify the SSD of usual residence of the patient, as SLAs are 
smaller areas that fit within SSDs. As with all information in the NHMD, the SLA 
information was provided to the AIHW by the state and territory health departments. In 
some cases, the SLA of usual residence was missing or based on outdated codes. Some 
jurisdictions provided SLA codes for patients usually resident in the jurisdiction, and 
postcodes for patients not usually resident in the jurisdiction. In these cases an SLA was 
assigned probabilistically by the AIHW using any available information on area of residence 
and taking into account ABS data on population distributions (AIHW 2011). Due to the 
probabilistic nature of this mapping the SLA of usual residence for individual records may, 
in a small number of cases, not be accurate; however, the overall distribution of records by 
geographical area is considered suitable for use in analyses of patterns of hospitalisations.  
B.2  SSDs not shown 
SSDs with fewer than 1,000 people in the age range of interest were not shown on the maps, 
and were excluded from the analysis in the report. 
For the asthma analysis, two SSDs had fewer than 1000 people in the age range 5–34, namely, 
Finniss in the Northern Territory, and the SSD covering the balance of the Australian Capital 
Territory. 
For the COPD analysis, eight SSDs had fewer than 1,000 people in the 55+ age range, namely, 
the SSD titled ‘Other Territories’ covering Jervis Bay, Christmas Island and the Cocos 
(Keeling) Islands, the SSD covering the balance of the Australian Capital Territory, as well as 
Carnegie in Western Australia and five SSDs in the Northern Territory: Barkly, Daly, 
Alligator, Bathurst-Melville and Finniss.  
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 B.3 SSD characteristics 
Socioeconomic status of the SSD 
This report uses the Index of Relative Socio-economic Advantage and Disadvantage 
(IRSAD). This index is one of several socioeconomic indexes derived by the ABS from 
information collected in the 2006 Census of Population and Housing. The IRSAD is an area-
based measure that represents the average level of socioeconomic advantage and 
disadvantage by SLA. SLAs are small geographic areas that can be combined together to 
form SSDs. The IRSAD is derived from attributes such as income, educational attainment 
and unemployment (ABS 2006a).  
In this report, the IRSAD scores by SLA (provided by the ABS) were used to calculate the 
IRSAD scores by SSD, as SLAs combine to form SSDs. To account for the varying sizes of the 
SSDs, the SLA IRSAD scores were weighted by the SLA population size before they were 
combined. The IRSAD score was then expressed in quintiles (five groups each containing 
20% of the SSDs in Australia). 
It is important to remember that the IRSAD score for an SSD is only an average score for the 
SSD. Therefore, an SSD with a low IRSAD score (indicating a high level of socioeconomic 
disadvantage) is likely to have a high proportion of relatively disadvantaged people. 
However, such an area will almost certainly include people who are not disadvantaged (ABS 
2006a).  
Remoteness of the SSD 
This report uses the remoteness classification by SSD based on the 2006 Australian Standard 
Geographical Classification (ASGC). The ASGC was derived by the ABS from information 
collected in the 2006 Census of Population and Housing. The remoteness classification uses 
Accessibility/Remoteness Index of Australia (ARIA) scores to determine remoteness areas. 
This index is calculated based on how distant a place is by road from urban centres of 
varying sizes, and therefore provides a relative indication of how difficult it might be for 
residents to access certain services, such as health care and education (ABS 2006b). 
There are five remoteness areas in this classification: Major cities, Inner regional, Outer regional, 
Remote and Very remote (ABS 2006b). In some cases an SSD fell across the boundary between 
remoteness areas. In these cases the remoteness area covering the largest portion of the 
population of the SSD was chosen. This issue affected 70% of the SSDs. For two-thirds of the 
affected SSDs, the chosen remoteness area covered 80% or more of the SSD population.  
Proportion of Indigenous Australians in the SSD 
This report uses the proportion of Indigenous Australians in each SSD, estimated by the 
ABS. The estimated Indigenous population comprises people who are of Aboriginal origin, 
Torres Strait Islander origin, or both Aboriginal and Torres Strait Islander origin (ABS 2008).  
The estimates are based on 2006 Census of Population and Housing counts of Aboriginal and 
Torres Strait Islander Australians adjusted for net undercount as measured by the Post 
Enumeration Survey. The extent of under-coverage of Aboriginal and Torres Strait Islander 
Australians in the 2006 Census and the relatively small sample size of the Post Enumeration 
Survey to adjust for that under-coverage means the estimates should be interpreted with 
caution (ABS 2008).  
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 Appendix C Poisson regression  
This appendix gives an overview of the technical approach used in fitting Poisson regression 
models to the hospitalisation data. The fitted models are shown in Appendix D.  
When the Poisson model was fitted to the hospitalisation data, there was overdispersion, 
where the variance of the data was greater than the mean of the data. The overdispersion 
was addressed by adjusting the statistical tests. The adjustments are outlined in Section C.1. 
An alternative method to address overdispersion is to use a more complex probability 
distribution for errors in the model, such as the negative binomial distribution. When a 
negative binomial model was fitted to the data, the data would not support credible 
estimation of the additional model parameter, so the Poisson model was a better choice.  
Collinearity is present in a regression when the explanatory variables are highly correlated. It 
is reasonable to expect that the three variables under study will be related to each other to a 
certain extent. Collinearity can be detected when a variable that was statistically significant 
in a single variable model does not make a statistically significant contribution to a model 
with an additional variable. Also, collinearity can be detected if the R2 for a combined model 
is smaller than the sum of the R2 for the variables run in separate models.  
SSDs that are close to each other may have more similar hospitalisation rates than SSDs that 
are further apart. This effect is called spatial autocorrelation. Spatial autocorrelation was not 
taken into account in the regression calculations in this report.  
C.1 Adjusting the Poisson regression statistical 
tests for overdispersion 
Overdispersion (where the variance of the data is greater than the mean of the data) was 
present when Poisson regression models were run on the data sets for asthma and COPD 
hospitalisations. This could be seen from the high values of the deviance divided by the 
degrees of freedom, where a value above 1 indicates overdispersion (UCLA 2012a). 
For the asthma data set, when Poisson models were run separately for each explanatory 
variable, the deviance divided by the degrees of freedom was 4.07 for the model using SES, 
6.63 for the model using remoteness and 7.09 for the model using the proportion of 
Indigenous Australians. The final model used just the SES explanatory variable. 
For the COPD data set, when Poisson models were run separately for each explanatory 
variable, the deviance divided by the degrees of freedom was 13.42 for the model using SES, 
21.24 for the model using remoteness and 21.73 for the model using the proportion of 
Indigenous Australians. The final model used two explanatory variables—SES and the 
proportion of Indigenous Australians—and the deviance divided by the degrees of freedom 
was 12.12. 
The statistical tests associated with these Poisson regression models were adjusted to account 
for the overdispersion. These adjustments are outlined here: 
Adjusting the standard errors and the test of model significance 
The Poisson model was adjusted to account for overdispersion by adding a scale term to the 
regression. The scale term was calculated using the formula: 
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scale term=�
deviance
degrees of freedom
 
 
(UCLA 2012a). This adjustment meant that the standard errors of the explanatory variables 
were recalculated by SAS. After the adjustment, SAS provided a scaled deviance, which was 
used in the place of the deviance in the chi-square goodness-of-fit test, which was used to 
test the statistical significance of the Poisson model (UCLA 2012b). 
Adjusting the generalised R2 
For a Poisson model, the generalised R2 can be calculated using the formula:  
 
generalised R2=1 −  
deviance
deviance of the model with all explanatory variables removed  
 
To account for overdispersion this formula can be adjusted to give:  
 
generalised R2=1−
deviance + number of explanatory variables * ( deviancedegrees of freedom )
deviance of the model with all explanatory variables removed 
 
 
(Heinzl & Mittlbock 2003). 
C.2 Poisson regression model form: 
To fit the Poisson model to rate data (the rate of asthma or COPD hospitalisations by SSD), 
the number of asthma hospitalisations by SSD was used as the response variable and the 
population size by SSD was used as an ‘offset’ term.  
The model has three possible explanatory variables: the SES of the SSD, the remoteness of the 
SSD and the proportion of the SSD population who were Indigenous Australians. 
This model can be written as: 
loge(y)=m + n*(ind(x1=1)) + o*(ind(x1=2)) + p*(ind(x1=3)) + q*(ind(x1=4)) 
+ r*(ind(x2=1)) + s*(ind(x2=2)) + t*(ind(x2=3)) + u*(ind(x2=4)) 
+ v*x3 
+ loge(z) 
where: 
y = average yearly asthma hospitalisations by SSD, for 2007–08 to 2009–10 
z = estimated population size by SSD, included in the regression model as an ‘offset’ term 
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 x1 = SES by SSD (measured using IRSAD, used in the model in the form of a categorical 
variable covering the quintiles 1–5, quintile 1 has the lowest SES, quintile 5 has the 
highest SES) 
x2 = Remoteness by SSD (used in the model in the form of a categorical variable covering the 
areas 1–5, where 1 = Major cities, 2 = Inner regional, 3 = Outer regional, 4 = Remote,  
5= Very remote) 
x3 = proportion of Indigenous Australians in the SSD (expressed as a percentage, 0–100) 
m = intercept term 
n–v = coefficient terms 
ind() = This is an indicator term for the expression in the brackets, equal to 1 when the 
expression is true, and 0 otherwise  
 
This model can be rearranged and exponentiated to give the hospitalisation rate on the left 
side of the equation: 
 
y/z = em * (en)ind(x1=1) * (eo) ind(x1=2) * (ep)ind(x1=3) * (eq) ind(x1=4) 
 * (er)ind(x2=1) * (es) ind(x2=2) * (et)ind(x2=3) * (eu) ind(x2=4) 
 * (ev) x3 
 
Once the model was fitted in SAS, the terms m–v can be added to the model as needed. 
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 Appendix D Fitted Poisson models 
D.1 Asthma hospitalisations 
The final model 
A Poisson regression model was fitted to the asthma hospitalisations data. All possible 
models using the three explanatory variables were tested. SES by SSD was used as the 
explanatory variable in the final model. The two other possible explanatory variables—
remoteness of the SSD and the proportion of Indigenous Australians by SSD—were not used 
in the model because they did not make a statistically significant contribution to the model 
once SES was included, likely due to the correlations between these variables.  
Table D1: The asthma hospitalisation model using SES by SSD as the explanatory variable  
Interpretation Estimated 
value 
Statistically 
significant? 
P value(a) Term(b) 
The factor increase in the hospitalisation rate for the lowest SES quintile 
compared with the highest SES quintile.  
2.05 Yes <0.0001 en 
The factor increase in the hospitalisation rate for the second-lowest SES 
quintile compared with the highest SES quintile. 
1.58 Yes <0.0001 eo 
The factor increase in the hospitalisation rate for the middle SES quintile 
compared with the highest SES quintile. 
1.64 Yes <0.0001 ep 
The factor increase in the hospitalisation rate for the second-highest 
SES quintile compared with the highest SES quintile. 
1.30 Yes <0.0001 eq 
Exponentiated intercept term 0.0010 Yes <0.0001 em 
(a) Assuming a chi-square distribution. 
(b) For the model form, see Appendix C, Section C.2. 
According to this model, the asthma hospitalisation rate was twice as high for SSDs in the 
lowest SES quintile than for SSDs in the highest SES quintile. The hospitalisation rate 
generally decreased as the level of advantage increased, with the exception that the asthma 
hospitalisation rate was higher for SSDs in the middle SES quintile than in the second-lowest 
SES quintile.  
Additional model information:  
• Generalised R2 for the model was 45%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.46 
allows rejection of the null hypothesis that the model does not fit well).  
• Scale term added to the model to adjust for overdispersion: 2.01.  
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 The models with each of the explanatory variables run separately 
Socioeconomic status by SSD 
See above. 
Remoteness by SSD 
The remoteness term by SSD was statistically significant (p<0.0002), but none one of the four 
remoteness level comparisons were statistically significant (p in the range of 0.45–0.98). 
Therefore, the full model is not shown here, as the values given to the level comparisons 
would be misleading.  
Additional model information:  
• Generalised R2 for the model was 10%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.47).  
• Scale term added to the model to adjust for overdispersion: 2.57.  
Proportion of Indigenous Australians by SSD 
Table D2: The asthma hospitalisation model using the proportion of Indigenous Australians in the 
SSD as the explanatory variable  
Interpretation Estimated 
value 
Statistically 
significant? 
P value(a) Term(b) 
The factor increase in the hospitalisation rate for each percentage 
increase in the proportion of Indigenous Australians in the SSD 
1.01 Yes <0.0001 ev 
Exponentiated intercept term 0.0014 Yes <0.0199 em 
(a) Assuming a chi-square distribution. 
(b) For the model form, see Appendix C, Section C.2. 
This formula shows that, according to this model, the asthma hospitalisation rate was higher 
in SSDs with a higher proportion of Indigenous Australians. The model predicts an increase 
in the hospitalisation rate by a factor of 1.01 for every percentage increase in the proportion 
of the SSD population who were Indigenous Australians. 
Additional model information:  
• Generalised R2 for the model was 2%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.48).  
• Scale term added to the model to adjust for overdispersion: 2.66.  
D.2 COPD hospitalisations 
The final model 
A Poisson regression model was fitted to the COPD hospitalisations data. All possible 
models using the three explanatory variables were tested. SES by SSD and the proportion of 
Indigenous Australians by SSD were used as the explanatory variables in the final model. 
The other possible explanatory variable, remoteness of the SSD, was not used in the model 
because it did not make a statistically significant contribution to the model once the other 
two variables were included, likely due to correlations with the other two variables.  
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 Table D3: The COPD hospitalisation model using SES and the proportion of Indigenous 
Australians in the SSD as the explanatory variables  
Interpretation Estimated 
value 
Statistically 
significant? 
P value(a) Term(b) 
The factor increase in the hospitalisation rate for each percentage 
increase in the proportion of Indigenous Australians in the SSD 
1.02 Yes <0.0001 ev 
The factor increase in the hospitalisation rate for the lowest SES quintile 
compared with the highest SES quintile.  
1.81 Yes <0.0001 en 
The factor increase in the hospitalisation rate for the second-lowest SES 
quintile compared with the highest SES quintile. 
1.56 Yes <0.0001 eo 
The factor increase in the hospitalisation rate for the middle SES quintile 
compared with the highest SES quintile. 
1.61 Yes <0.0001 ep 
The factor increase in the hospitalisation rate for the second-highest 
SES quintile compared with the highest SES quintile. 
1.28 Yes <0.0001 eq 
Exponentiated intercept term 0.0073 Yes <0.0001 em 
(a) Assuming a chi-square distribution. 
(b) For the model form, see Appendix C, Section C.2. 
Based on this model, COPD hospitalisation rates were higher in SSDs with a higher 
proportion of Indigenous Australians by a factor of 1.02 for every percentage increase in the 
proportion of Indigenous Australians. The model also found that COPD hospitalisation rates 
were larger by a factor of 1.8 in SSDs in the lowest SES quintile compared with SSDs in the 
highest SES quintile. The COPD hospitalisation rate decreased as the level of SES advantage 
increased, with the exception of quintile 3, the middle quintile, which had a slightly higher 
hospitalisation rate than quintile 2, the second-lowest SES quintile.  
Additional model information:  
• Generalised R2 for the model was 55%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.48).  
• Scale term added to the model to adjust for overdispersion: 3.48.  
The models with each of the explanatory variables run separately 
SES by SSD 
Table D4: The COPD hospitalisation model using SES by SSD as the explanatory variable  
Interpretation Estimated 
value 
Statistically 
significant? 
P value(a) Term(b) 
The factor increase in the hospitalisation rate for the lowest SES quintile 
compared with the highest SES quintile.  
1.95 Yes <0.0001 en 
The factor increase in the hospitalisation rate for the second-lowest SES 
quintile compared with the highest SES quintile. 
1.60 Yes <0.0001 eo 
The factor increase in the hospitalisation rate for the middle SES quintile 
compared with the highest SES quintile. 
1.65 Yes <0.0001 ep 
The factor increase in the hospitalisation rate for the second-highest 
SES quintile compared with the highest SES quintile. 
1.30 Yes <0.0001 eq 
Exponentiated intercept term 0.0073 Yes <0.0001 em 
(a) Assuming a chi-square distribution. 
(b) For the model form, see Appendix C, Section C.2. 
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 This model found that COPD hospitalisation rates were larger by a factor of 2 for SSDs in the 
lowest SES quintile compared with SSDs in the highest SES quintile. The COPD 
hospitalisation rate decreased as the level of SES advantage increased, with the exception of 
SSDs in the middle quintile, which had a slightly higher hospitalisation rate than SSDs in the 
second-lowest SES quintile.  
Additional model information:  
• Generalised R2 for the model was 50%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.48).  
• Scale term added to the model to adjust for overdispersion: 3.66.  
Remoteness by SSD 
The remoteness term by SSD was statistically significant (p<0.0001), but none one of the four 
remoteness level comparisons were statistically significant (p in the range of 0.07–0.71). 
Therefore, the full model is not shown here, as the values given to the level comparisons 
would be misleading.  
Additional model information:  
• Generalised R2 for the model was 21%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.49). 
• Scale term added to the model to adjust for overdispersion: 4.61.  
Proportion of Indigenous Australians by SSD 
Table D5: The COPD hospitalisation model using the proportion of Indigenous Australians in the 
SSD as the explanatory variable  
Interpretation Estimated 
value 
Statistically 
significant? 
P value(a) Term(b) 
The factor increase in the hospitalisation rate for each percentage 
increase in the proportion of Indigenous Australians in the SSD 
1.03 Yes <0.0001 ev 
Exponentiated intercept term 0.010 Yes <0.0001 em 
(a) Assuming a chi-square distribution. 
(b) For the model form, see Appendix C, Section C.2. 
This model found that the COPD hospitalisation rate was higher in SSDs with a higher 
proportion of Indigenous Australians. The model predicts an increase in the hospitalisation 
rate by a factor of 1.03 for every percentage increase in the proportion of the SSD population 
who were Indigenous Australians. 
Additional model information:  
• Generalised R2 for the model was 18%.  
• The goodness-of-fit chi-square test showed that the model fitted the data well (p=0.48).  
• Scale term added to the model: 4.66.  
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This report investigates how hospitalisation rates for 
asthma and chronic obstructive pulmonary disease 
(COPD) vary across Australia. Maps in the report show 
higher hospitalisation rates for both asthma and COPD in 
inland and rural areas of Australia. 
Socioeconomic status, remoteness and the proportion 
of the population that identifies as Indigenous all have a 
significant association with the hospitalisation rates for 
asthma and COPD by area.
